About MARR

Antibiotic resistance has been called one of the world’s most pressing public health problems. The number of bacteria resistant to antibiotics has increased in the last decade. The Michigan Antibiotic Resistance Reduction (MARR) Coalition was formed in 1997 through a grant from General Motors Corporation to help reduce unnecessary antibiotic prescribing in Michigan. Since then, we have grown to include a broad coalition of local professional and community organizations, and individuals focused on the issue of unwarranted use of antibiotics in treating self-limiting respiratory ailments, like colds, flu and most coughs. The MARR Coalition is funded by the Centers for Disease Control and Prevention (CDC) Get Smart: Know When Antibiotics Work initiative.

MARR Project Mission:

The Michigan Antibiotic Resistance Reduction Coalition (MARR) seeks to improve the use of antimicrobial agents and reduce antimicrobial resistance rates in communities throughout the state of Michigan through the collaborative efforts of academic, community, government, labor, and industry partners.

The MARR Coalition strives to:

• Provide the infrastructure and resources for positive interventions that support the appropriate use of antibiotics and reduce antibiotic resistance in Michigan, including:
  • Educational interventions designed to change provider-prescribing habits and improve patient communication skills.
  • Consumer educational programs about appropriate antibiotic use.
• Reduce antimicrobial resistance in the state of Michigan and share our information nationally.
• Provide a forum for bringing together stakeholders who share the goal of antimicrobial resistance reduction.
• Secure accurate data on the antibiotic prescribing habits of health care providers in the outpatient setting.
• Secure accurate data on consumer use of antibiotics.